Finnish companies are making substantial advancements in healthcare, showcasing progress in various areas such as determining the efficacy of analgesics, providing remote biometric testing access, medication dispensing through a video link, and entering the medical devices market with simplified regulatory processes.
Fepod’s Breakthrough Analgesic Efficacy Tool:
Fepod announced a significant milestone in June, securing €750,000 in seed funding from Almaral, a Finnish venture capital firm specializing in early-stage biotechnology and life sciences startups. Fueled by this funding, the Aalto University-based startup is advancing the clinical trials of its in-vitro tool designed to measure the concentration of analgesics like opioids and paracetamol in the blood. This innovative analytics tool provides rapid results within seconds, offering a more efficient and accessible alternative to traditional laboratory methods.
Innokas Medical Streamlines Regulatory Processes:
Innokas Medical, based in Kempele, introduces the “MDR Fast Track” service, allowing companies to outsource regulatory work associated with entering the highly regulated medical device market. By taking on the role of a responsible manufacturer, Innokas Medical handles regulatory compliance, enabling clients to focus on core activities. This initiative addresses the challenges posed by the EU’s Medical Device Regulation, ensuring smoother market entry for new technologies in healthcare.
Nightingale Health Expands into New Markets:
Nightingale Health reported plans to enter three new markets through a partnership with UK-based digital healthcare company Physitrack. This collaboration facilitates the launch of Nightingale’s at-home blood testing service, Livit, in Germany, the UK, and the Nordics. Users of Physitrack’s wellness product, Access, can now benefit from advanced blood test-based feedback, combining digital health coaching services with preventative health insights.
Evondos Introduces Medication-Dispensing Robot:
Salo-based Evondos unveils Evondos Anna, a medication-dispensing robot equipped with video capabilities. This innovation allows medication dispensing during virtual appointments with healthcare professionals, enhancing flexibility in-home care. Evondos Anna’s video functionality proves valuable for individuals living at home but requiring additional support with medication. The startup’s expansion into the Spanish market further strengthens its commitment to supporting safe pharmacological therapies and promoting independent living.
These groundbreaking initiatives reflect Finland’s commitment to advancing healthcare solutions, emphasizing innovation, accessibility, and streamlined regulatory processes. The announcements coincide with the 2022 HIMSS European Health Conference & Exhibition in Helsinki, where Finnish companies showcase their expertise in digital health, paving the way for the future of healthcare practices.